Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

Abstract Background The purpose of this study was to conduct a 20-week controlled trial of lovastatin (10 to 40 mg/day) in youth with fragile X syndrome (FXS) ages 10 to 17 years, combined with an open-label treatment of a parent-implemented language intervention (PILI), delivered via distance video...

Full description

Bibliographic Details
Main Authors: Angela John Thurman, Laura A. Potter, Kyoungmi Kim, Flora Tassone, Amy Banasik, Sarah Nelson Potter, Lauren Bullard, Vivian Nguyen, Andrea McDuffie, Randi Hagerman, Leonard Abbeduto
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Journal of Neurodevelopmental Disorders
Subjects:
Fragile X syndrome
Lovastatin
Distance teleconferencing
Expressive language sampling
Narrative storytelling
Parent-implemented language intervention
Online Access:http://link.springer.com/article/10.1186/s11689-020-09315-4

Internet

http://link.springer.com/article/10.1186/s11689-020-09315-4

Similar Items